Watchdog clears £2.9bn Viagogo and StubHub merger September 8, 2021 A $4bn (£2.9bn) merger of ticket resale websites Viagogo and StubHub has been approved by a UK watchdog. Viagogo was given the green light to acquire StubHub after US investment group Digital Fuel Capital agreed to buy part of the business. The Competition and Markets Authority (CMA) had instructed Viagogo to sell StubHub’s operations to [...]
US Nvidia’s $54bn UK Arm buyout faces EU competition concerns September 7, 2021 European Union officials have reportedly voiced competition concerns over US tech giant Nvidia’s purchase of UK chip design company Arm, in the deal’s latest wave of opposition. The Competition and Markets Authority (CMA) echoed the EU’s sentiment last month, saying the sale raises “serious competition concerns.” The California-based company is preparing to file for regulatory [...]
PCR test firm for travel being investigated over results, refunds and service September 3, 2021 One of the UK’s largest and cheapest PCR test companies focussed on travel is under investigation by the competition watchdog over several service failings. Expert Medicals faces allegations that tests and results were not provided in a timely manner, or at all in some cases, bosses failed to respond to complaints and refunds were not [...]
EU to investigate Nvidia’s $54bn purchase of Arm August 27, 2021 Brussels is preparing to open an investigation into Nvidia’s acquisition of Arm as a result of competition concerns. Nvidia plans to notify the EU of its intention to purchase Cambridge-based technology company Arm in the first week of September. Two sources with detailed information of the process told the Financial Times that when Nvidia officially [...]
Competition watchdog blasts PCR test firms over consumer law breaches August 25, 2021 The UK competition watchdog has warned of a potential crackdown on PCR Covid test providers amid concerns they may be breaking consumer law. In an open letter the Competition and Markets Authority (CMA) raised concerns about a number of harmful practices in the sector. These included advertising up-front prices for PCR tests that do not [...]
CMA watchdog warns ARM sale raises ‘serious competition concerns’ August 20, 2021 The Competition and Markets Authority (CMA) has said that NVIDIA’s purchase of Arm raises serious competition concerns. The report, which has been sent to Oliver Dowden, the Secretary of State for Digital, said an “in-depth investigation” into the $40bn deal between Arm and NVIDIA is warranted. The CMA highlighted that NVIDIA and Arm are both [...]
UK competition watchdog to investigate Central England Co-op funeral deal August 16, 2021 The Competition and Markets Authority (CMA) will investigate the deal by the Central England Co-op to snap up part of its rival in the funeral care business, the Midcounties Co-op. The UK competition regulator said today it is considering whether the merger deal “may be expected to result in a substantial lessening of competition” within [...]
UK competition watchdog investigating ‘immediate’ government action on PCR test prices August 13, 2021 The UK competition regulator has said it is exploring what immediate action the government can take to quash the hugely variable prices charged by private providers of Covid PCR tests for travel, after the health secretary, MPs and the travel industry called for an intervention. In a statement published yesterday, the Competition and Markets Authority [...]
CMA accuses pharma firms Pfizer and Flynn of charging NHS illegal prices for anti-epilepsy drug August 5, 2021 The UK’s competition watchdog has accused pharmaceutical firms Pfizer and Flynn of breaking competition law and overcharging the NHS for crucial anti-epilepsy drugs, in a new re-investigation following a years-long battle with the companies. Pfizer and Flynn “abused their dominant positions” and charged the NHS “unfairly high prices” for life-saving phenytoin sodium capsules, for which they [...]
CMA hits firms with £100m in fines for making drugs unaffordable for the NHS July 29, 2021 Drug company Advanz, as well as two private equity firms, have been hit with fines of over £100m by the UK’s competition watchdog for hiking vital drug prices. The investigation found that Advanz pushed up prices for thyroid tablet packs, known as liothyronine tablets, more than tenfold. A pack would have cost just £20 in [...]
